← Browse by Condition
Medical Condition
dyslipidemias
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 2, Phase 4
ClinicalMetric tracks all active clinical trials for dyslipidemias sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — dyslipidemias Clinical Trials
How many clinical trials are currently recruiting for dyslipidemias?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for dyslipidemias, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for dyslipidemias?
dyslipidemias research spans Phase 2 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a dyslipidemias clinical trial?
Eligibility criteria for dyslipidemias trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Phase 4 1
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06300450
Recruiting
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
Enrollment
400 pts
Location
United States
Sponsor
Brigham and Women's Hospital
NCT05988866
Recruiting
Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels
Enrollment
272 pts
Location
Germany
Sponsor
Gaia AG
NCT06496243 Phase 2
Recruiting
Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels
Enrollment
69 pts
Location
United States
Sponsor
NewAmsterdam Pharma
NCT05845424 Phase 4
Recruiting
High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium
Enrollment
6,000 pts
Location
South Korea
Sponsor
Samsung Medical Center
NCT07523971
Recruiting
Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study
Enrollment
10,000 pts
Location
South Korea
Sponsor
JW Pharmaceutical
NCT06526650
Recruiting
'Ai Pono Cooking Demonstrations
Enrollment
1,780 pts
Location
United States
Sponsor
University of Hawaii
NCT05881447
Recruiting
Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
Enrollment
1,200 pts
Location
Tanzania
Sponsor
Swiss Tropical & Public Health...
NCT06526273
Recruiting
PILI 'Āina Household
Enrollment
210 pts
Location
United States
Sponsor
University of Hawaii
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology